This article originally appeared on fda.gov. To see the full article, click here. July 2nd, 2020- Today, the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried […]
The following Op-Ed was written by Dr. Nina Harawa, CHIPTS Policy Impact Core Director. The full article published on indystar.com is available here. Nina T. Harawa July 8, 2020 6:00 AM As America labors under the effects of a global […]
July 9th, 2020- CHIPTS is excited to share preliminary reports from our three Ending the HIV Epidemic (EHE) supplement projects. These one-year, formative projects were funded by the National Institute of Mental Health to enhance the implementation science knowledge base […]
This article originally appeared on niaid.nih.org. To see the full article, click here. July 7th, 2020- A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks was more effective than […]
This article originally appeared on hptn.org. To see the full article, click here. DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every 8 weeks was superior to daily oral tenofovir/emtricitabine (TDF/FTC) for HIV prevention among cisgender […]
This article originally appeared on aidsvu.gov. To see the full article, click here. ATLANTA – April 15, 2020 – AIDSVu today announced the release of new interactive county-level data and maps visualizing PrEP use from 2012 to 2018, showing a 39% increase in PrEP use across the U.S. […]
April 16th, 2020- A critical call to action was voiced in a recent publication co-authored by Drs. Steve Shoptaw, Raphael Landovitz, and David Goodman-Meza, faculty members of UCLA CHIPTS. The article, entitled “Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in […]
This article originally appeared on hhs.gov. To see the full article, click here. Today, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded $90 million for Ryan White HIV/AIDS Program recipients […]
This article originally appeared on aidsinfo.nih.gov. To see the full article, click here. This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. Information and data on COVID-19 are […]
New emerging evidence from a systematic review of the safety of PrEP for pregnant and postpartum women has been released in a new publication co-authored by CHIPTS members Dvora Davey, Thomas Coates, and Steven Shoptaw, Director of CHIPTS. The abstract […]